Machine Learning

Alpha Modus is deploying its ARIA platform with Greer's Markets, aiming to transform fragmented legacy data into operational AI without a costly IT overhaul.

Builders are pouring millions into AI to fix labor shortages and project delays. But as legal risks mount, the true return on investment remains a mystery.

As supply chain pressures mount, a Swiss deep-tech firm balances European manufacturing alliances with a massive $30 million scaling play in India.

A new strategic partnership between Evosep and Mass Dynamics aims to solve proteomics’ biggest bottleneck: pre-analytical variability in drug discovery.

As third-party cookies crumble, Valuedynamx names Emma Kisby CEO to spearhead a £500 million investment into AI-driven, card-linked loyalty commerce.

Beyond the generative AI hype, real-world enterprise infrastructure demands heterogeneous model serving and strict FinOps. Arcfra’s latest release delivers both.

In a major U.S.-Japan-Australia military exercise, startup Gallatin AI’s predictive software provided a critical logistical edge, signaling a new era for allied readiness.

With new patents in Australia and Japan, Leveragen isn't just protecting its tech. It's building a data-rich biological engine for AI-driven medicine.

As Southeast Asia grapples with rampant energy theft and grid strain, a Silicon Valley firm’s AI platform signals a major shift from collecting data to creating value.

JATT III Acquisition Corp's $60M IPO isn't just another SPAC. It’s a calculated bet by a proven team on the future of AI in drug discovery. But does it signal a new era for biotech M&A?

A new patent for an 'evolving' digital ID promises to fight fraud and boost financial inclusion. But what does a continuous identity profile mean for us?

Agoda and Singapore's Tourism Board are ditching old marketing playbooks for a new AI-powered strategy to create hyper-personalized travel and a smarter economy.

Infios's dual leadership in IDC MarketScape reports for B2B and B2C signals a new era where unified, AI-driven execution is no longer optional.

Neonode's Q2 report shows shrinking revenue and widening losses, but a massive jump in MultiSensing® license sales points to a deliberate, high-stakes bet on the automotive sector.

RyboDyn's RyboCypher platform is uncovering a 'dark proteome' full of tumor-specific targets, promising a new era beyond today's crowded drug pipeline.

Digital games marketplace Kinguin was a magnet for fraudsters—until it wasn't. See how its AI partnership with Ravelin cut fraud by 87.5%.

OTraces' new AI analyzes biological 'noise' to forecast Type 1 Diabetes with over 92% accuracy, promising a new era of early intervention and care.

Kiavi's rapid growth is more than a number on a list. It's a story of AI, strategic acquisition, and the quiet revitalization of American housing.

AI lab Pathway has unveiled a model that runs advanced reasoning tasks 11x cheaper than OpenAI's GPT 5.6, using a novel 'latent reasoning' architecture.

More than a new logo, Trimedx's evolution highlights a critical shift where data, AI, and cybersecurity are becoming the lifeblood of hospital operations.